IW 404

September 30, 2026 Viktor Zarev 0 min read
  1. CMS launches Medicaid quality partnership with 37 states.
  2. Sham scientific societies are misleading star researchers.
  3. Senate panel advances pair of HHS nominations.
  4. Memorial Hermann CEO to retire, CFO named successor.
  5. Med school enrollment up 37% in two decades.
  6. Texas health system sets world record as largest medical center.
  7. FDA releases draft guidance on robotically-assisted surgical devices.
  8. Oz expects AI to “turbocharge” healthcare costs in the near term.
  9. ‘Zombified’ CDC, hobbled by cuts, struggles to fulfill scientific mission.
  10. How to combat AI-fueled biological weapons.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Structural Heart October 5, 2026

The Double Firsts of Edwards’ Autus Approval October 5, 2026

Children born with congenital pulmonary valve disease no longer need repeat surgeries throughout childhood with the FDA approval of Edwards Lifesciences' Autus Size-Adjustable Valve.

Cardiology Practices October 2, 2026

Can Rural Cardiology Be Revived? October 2, 2026

Nearly nine in ten rural counties lack a cardiologist and a new survey of the physicians serving the other 10% revealed that the issue runs deeper than […]

Cardiology Pharmaceuticals October 1, 2026

A New King of The GLP-1s Could Be Crowned October 1, 2026

Ladies and gents, Eli Lilly has outdone itself again, with the Phase 3 results of its triple GLP-1/GIP/glucagon receptor agonist, retatrutide, showing astonishing weight loss results for patients with obesity.